Yaron Naos
2022
In 2022, Yaron Naos earned a total compensation of $533.3K as Senior Vice President, Operations at Protalix BioTherapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $81,176 |
|---|---|
| Option Awards | $123,310 |
| Salary | $239,201 |
| Other | $89,578 |
| Total | $533,265 |
Naos received $239.2K in salary, accounting for 45% of the total pay in 2022.
Naos also received $81.2K in bonus, $123.3K in option awards and $89.6K in other compensation.
Rankings
In 2022, Yaron Naos' compensation ranked 4,249th out of 5,756 executives tracked by ExecPay. In other words, Naos earned more than 26.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,249 out of 5,756 | 26th |
Division Manufacturing | 2,398 out of 3,133 | 24th |
Major group Chemicals And Allied Products | 1,165 out of 1,419 | 18th |
Industry group Drugs | 1,093 out of 1,320 | 17th |
Industry Biological Products, Except Diagnostic Substances | 258 out of 291 | 11th |
Source: SEC filing on May 18, 2023.
Naos' colleagues
We found two more compensation records of executives who worked with Yaron Naos at Protalix BioTherapeutics in 2022.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020
Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
April 12, 2019